Armata Pharmaceuticals Inc. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2021. For the quarter, the company reported revenue of $1,168,000 compared to $31,000 a year ago. Loss from operations was $6,196,000 compared to $4,590,000 a year ago. Net loss was $6,194,000 compared to $4,710,000 a year ago. Basic and diluted net loss per shares was $0.25 compared to $0.26 a year ago. For the six months, the company reported revenue of $2,234,000 compared to $31,000 a year ago. Loss from operations was $11,631,000 compared to $9,511,000 a year ago. Net loss was $11,689,000 compared to $9,788,000 a year ago. Basic and diluted net loss per shares was $0.52 compared to $0.68 a year ago.